What changed
Silexion Therapeutics Corp issued a warrant adjustment notice effective after the close of trading on November 10, 2026, tied to its 1-for-24 reverse share split. Each pre-split warrant to purchase one ordinary share now covers 1/24th of an ordinary share, and the exercise price rose 24-fold to $372,600.00 per post-split ordinary share. Fractional shares from warrant exercises will be rounded up to the nearest whole share at the broker level, with holders paying the full exercise price for that whole share. The warrant CUSIP G1281K 114 and symbol SLXNW remain unchanged.
Why it matters
Silexion Therapeutics Corp issued a warrant adjustment notice effective after the close of trading on November 10, 2026, tied to its 1-for-24 reverse share split. Each pre-split warrant to purchase on